GLESSNER COLEEN (EVP, Quality & Ethics, and CPL) reported 1 transaction at EMERGENT BIOSOLUTIONS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/3/2026ACC: 0001919170-26-000006
Officer· EVP, Quality & Ethics, and CPL
Since Mar 2022
-313.00
Net shares
Net seller
$2.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
313.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−313.00
Price / share
$8.15
Trade value
$2.55K
% of position
0.3%
3/1/2026
112.62K→112.31K
Total
Net shares
−313.00
Net value
-$2.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2026 | F · Tax Withholding | −313.00 | $8.15 | $2.55K | 0.3% | 112.62K | 112.31K |
| Total | −313.00 | -$2.55K | ||||||
Derivative Transactions0
No derivative transactions reported